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Edited by Veli-Pekka LehtoAbstract Many types of organ-speciﬁc stem cells have been
recently shown to exhibit a side population (SP) phenotype based
on their ability to eﬄux Hoechst 33342 dye. Because stem cells
from corneal epithelium reside in the basal layer of the limbal
epithelium, the purpose of this study was to examine whether the
limbal epithelium contains SP cells. The ATP-binding cassette
transporter Bcrp1/ABCG2 is reported to contribute to the SP
phenotype in cells from several diverse sources. Here we show
data from ﬂuorescence-activated cell sorting and real-time
quantitative RT-PCR analysis showing that harvested limbal
epithelial cells contain SP cells expressing ABCG2. Immunoﬂu-
orescence revealed that a portion of limbal epithelial basal cells
expressed ABCG2. Data indicate that ABCG2 positive limbal
epithelial cells are putative corneal epithelial stem cells.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The cornea – the transparent outer anterior tissue layer of
the eye – provides the eye with protection and refractive
properties essential for vision. These functions depend, in part,
on the corneal epithelium, a highly specialized cell layer
comprising both basal and stratiﬁed squamous cells. Corneal
epithelial stem cells reside in the basal layer of the limbus [1,2],
the transitional zone between the cornea and the more pe-
ripheral bulbar conjunctiva. These cells allow the renewal of
the corneal epithelium by generating transient amplifying cells
that migrate, proliferate and diﬀerentiate to replace lost cor-
neal epithelial cells [3–5]. However, because of the absence of
the deﬁnite biological markers, unequivocal corneal epithelial
stem cell identiﬁcation remains elusive.
In 1996, Goodell et al. [6] demonstrated that mouse
hematopoietic stem cells with long-term multi-lineage reconsti-
tuting ability can be isolated as side population (SP) cells based* Corresponding author. Fax: +81-6-6879-3458.
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doi:10.1016/j.febslet.2004.03.064on their ability to eﬄux the Hoechst 33342 dye. Using dual
wavelength ﬂow cytometric analysis, SP cells were identiﬁed as
a distinct population with low Hoechst 33342 blue/red ﬂuo-
rescence representing approximately 0.1% of total bone mar-
row cells [6]. SP cells have also been identiﬁed in hematopoietic
compartments in a number of animals [7–10]. In addition, SP
cells have been isolated from various types of adult tissue
where they demonstrate stem cell activity [6,10–16]. These
ﬁndings suggest that the SP phenotype represents a common
feature of stem cells.
Recently, Zhou et al. [13,17] reported that the ATP-binding
cassette transporter Bcrp1/ABCG2 is a molecular determinant
of the SP phenotype. A number of other studies in a wide
variety of organs have also indicated that the SP phenotype is
largely determined by the expression of Bcrp1/ABCG2
[13,15,18–20]. More recently, Mogi et al. [21] have shown by
targeted gene ablation studies in mice that serine/threonine
kinase Akt signaling modulates the SP phenotype by regulat-
ing the expression of Bcrp1/ABCG2.
At present, it remains unclear if corneal epithelial stem cells
might exhibit the SP phenotype. We report our recent studies
on human limbal epithelium, providing evidence that these
cells contain SP cell subsets expressing ABCG2, implicating
possible relationships between these SP cells and limbal stem
cells.2. Materials and methods
2.1. Cell preparation
Human corneoscleral rims from USA eye bank eyes were used.
Limbal tissues were obtained by using scissors, and 8.0-mm diameter
central portions of corneas were obtained by trephination. Limbal
tissues and central corneas were incubated separately at 37 C in
Dulbecco’s modiﬁed Eagle’s medium (DMEM; Nikken Biomedical
Laboratory, Kyoto, Japan) containing 2.4 units/ml dispase (Invitro-
gen, Carlsbad, CA) for 1 h. Epithelial cells were separated under a
dissecting microscope and treated with 0.25% trypsin-1 mM EDTA
solution (Invitrogen) for 15 min at 37 C to achieve each single cell
suspensions from the limbal epithelium and the corneal epithelium.
Enzymatic activity was then stopped by adding an equal volume of
DMEM containing 10% fetal calf serum (FCS; Morgate Biotech, Qld.,
Australia).
2.2. Hoechst 33342 dye exclusion assay
Separate populations of epithelial cells from the limbus and from the
cornea were resuspended at 1.0 106 cells/ml in incubation mediumblished by Elsevier B.V. All rights reserved.
Fig. 1. Flow cytometric analysis of epithelial cells harvested from the
limbus and from the cornea. Epithelial cells were isolated from eye
bank limbus and cornea tissues, and analyzed for Hoechst 33342 dye
eﬄux by FACS. (A) SP cells were detected in limbal epithelial cells
after Hoechst 33342 dye staining. (B) SP cells were absent in corneal
epithelial cells. (C) Dye eﬄux from SP cells was inhibited by verapamil.
(D) Verapamil had no eﬀect on dye eﬄux.
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sequently divided into two portions. After incubation in incubation
medium for 90 min at 37 C, (R)+-verapamil (Sigma, St. Louis, MO)
or tryprostatin A (TPS-A; provided by Dr. H. Osada (RIKEN Insti-
tute)) was added to one portion (ﬁnal concentration: 50 lM), after
which both portions were incubated for a further 30 min at 37 C.
Antibody-mediated inhibition assay using anti-ABCG2 monoclonal
antibody (5D3; eBioscience, San Diego, CA) or isotype control (mouse
IgG2b; eBioscience) was performed as previously described [22].
Hoechst 33342 dye (Sigma) was then added to both portions (ﬁnal
concentration: 3 lg/ml), and incubation continued for another 90 min
at 37 C. After the ﬁnal incubation, cells were kept on ice and analyzed
for Hoechst 33342 dye eﬄux by EPICS Altra FACS analysis (Beckman
Coulter, Fullerton, CA). Prior to analysis, propidium iodide (Sigma)
was added (ﬁnal concentration: 2 lg/ml) to distinguish live from dead
cells. Hoechst 33342 dye was excited at 350 nm using a UV laser.
Fluorescence emission was detected through 450 nm BP (Hoechst blue)
and 675 nm LP (Hoechst red) ﬁlters, respectively. Propidium iodide in
cells was excited at 488 nm (argon ion laser) and ﬂuorescence emission
was detected through a 610 nm BP ﬁlter.
2.3. Real-time quantitative RT-PCR analysis
SP and non-SP cells were isolated from limbal epithelial cells using
EPICS Altra ﬂow cytometric sorting. Total RNA was obtained from
equal numbers (2000–3000) of SP and non-SP cells according to the
manufacturer’s instructions (Isogen; Nippongene, Tokyo, Japan). Af-
ter DNase I (Invitrogen) treatment, total cellular RNA was divided
into two portions. One portion was reverse transcribed with ol-
igo(dT)12–18, according to the manufacturer’s instructions (SuperScript
First-Strand Synthesis System for RT-PCR; Invitrogen), and a 1/10
volume (2 ll) of synthesized cDNA was used as a template for PCR.
The other portion was treated in the same manner except for the
omission of SuperScript II reverse transcriptase (Invitrogen). The oli-
gonucleotide primers (Invitrogen) used for ABCG2 ampliﬁcation were
50-GGTTTCCAAGCGTTCATTCAAA-30 (forward) and 50-TAG-
CCCAAAGTAAATGGCACCTA-30 (reverse), with an expected prod-
uct length of 111 bp. The TaqMan probe (Applied Biosystems, Foster
City, CA) used for ABCG2 detection was 50-CCCAGGCCTCTA-
TAGCTCAGATCATTGTCA-30, labeled with 6-carboxyﬂuorescein
(FAM) at the 50-end, and with 6-carboxytetraethylrodamine (TAM-
RA) at the 30-end. Quantitative PCR was performed using ABI Prism
7900HT Sequence Detection System (Applied Biosystems), according
to the manufacturer’s instructions. The reaction mixture (30 ll) con-
tained 15 ll of TaqMan Universal PCR Mastermix (Applied Biosys-
tems), 15 pmol of forward and reverse primers, 7.5 pmol of TaqMan
probe and 2 ll of the investigated sample. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression was measured using TaqMan
GAPDH Control Reagents (Applied Biosystems), according to the
manufacturer’s instructions. Thermocycling used 50 cycles at 95 C for
15 s and 60 C for 1 min with an initial cycle at 50 C for 2 min and
95 C for 10 min. A negative control with non-reverse transcribed total
RNA as a template was included in every experiment. All assays were
run in duplicate. To represent the ABCG2 mRNA expression level, we
used the ABCG2 mRNA expression index as the value of the ABCG2
gene copies divided by the value of the housekeeping GAPDH gene
copies.
2.4. Statistical analysis
Statistics were calculated using SigmaStat 2.0 (SPSS, Chicago, IL).
To compare ABCG2 expression between SP and non-SP cells, the
Mann–Whitney rank sum test was applied.
2.5. Immunoﬂuorescence
Cryostat sections (20 lm) were cut from the limbus and from the
cornea, dried for 1 h at room temperature, and ﬁxed in acetone for 10
min also at room temperature. Immunoﬂuorescence was performed
using DakoCytomation CSA II (DakoCytomation, Kyoto, Japan).
Brieﬂy, endogenous peroxidase activity was blocked with 3% hydrogen
peroxide in water for 15 min. The slides were ﬁrst incubated with
serum-free protein in buﬀer for 15 min to block non-speciﬁc binding of
antibodies, then incubated at 4 C overnight with a 1:2500 dilution of
BXP-21 monoclonal antibody (MBL, Aichi, Japan). BXP-21 was
diluted in tris-buﬀered saline containing 1% bovine serum albumin and
0.1% Tween 20. After incubation, slides were incubated for 15 min
with anti-mouse immunoglobulins-HRP, followed by 15 min inﬂuorescyl-tyramide hydrogen peroxide in buﬀer. After counterstaining
with propidium iodide (Sigma), slides were mounted and observed on
a confocal laser scanning microscope (LSM 510 META; Carl
Zeiss, Jena, Germany). For each type of tissue, identically treated
negative controls were included using normal non-speciﬁc IgG2a
(DakoCytomation).3. Results
3.1. SP cells are present in human limbal epithelium
In the Hoechst 33342 dye exclusion assay, a distinct popu-
lation of cells with a low Hoechst 33342 blue/red ﬂuorescence
was detected in epithelial cells from the limbus (Fig. 1A; 0.20%
gated cells) but not in cells from the cornea (Fig. 1B, 1D;
0.02% gated cells). Generation of this subpopulation was not
seen in the presence of (R)+-verapamil, the speciﬁc inhibitor of
Hoechst 33342 dye transport (Fig. 1C; 0.01% gated cells).
These observations indicate that the limbal epithelium con-
tains SP cells.
3.2. Eﬀect of 5D3 and TPS-A on Hoechst 33342 dye eﬄux
When SP cells were incubated with an anti-ABCG2 mono-
clonal antibody, 5D3, recognizing an external plasma mem-
brane epitope on living cells [13,22], prior to Hoechst 33342
dye exclusion assay, a marked decrease in SP cell dye eﬄux
was observed (Fig. 2A). Hoechst 33342 dye eﬄux activity was
also inhibited by a novel ABCG2 inhibitor, TPS-A (Fig. 2B),
that is known not to inhibit another important ATP-binding
cassette transporter, P-glycoprotein [23]. These data strongly
suggest that ABCG2 is a major contributor to the SP pheno-
type of limbal epithelial cells.
3.3. ABCG2 mRNA expression in SP and non-SP cells
To investigate the link between the SPphenotype andABCG2
expression, SP and non-SP cells from limbal epithelial tissues
were analyzed forABCG2gene expressionbyTaqMan real-time
Fig. 3. Quantiﬁcation of ABCG2 mRNA in SP and non-SP cells. (A)
Ampliﬁcation plots from real-time RT-PCR analysis. Delta Rn is
plotted against cycle number. Horizontal red lines show the threshold
used for calculation of ABCG2 expression indices. Real-time quanti-
tative RT-PCR procedures were as described in Section 2. (B) ABCG2
mRNA expression indices in SP and non-SP cells. The relative ex-
pression of ABCG2 gene was normalized to that of GAPDH in each
sample. Data represent the mean value from four samples. Error bars
indicate the S.E. ABCG2 mRNA expression in SP cells was signiﬁ-
cantly higher than in non-SP cells (P ¼ 0:029).
Fig. 2. Inﬂuence of ABCG2 inhibitors on the SP phenotype of limbal
epithelial cells. Limbal epithelial cells were analyzed for Hoechst 33342
dye eﬄux in the presence of ABCG2 inhibitors. Dye eﬄux from SP
cells was eﬀectively inhibited by 5D3 monoclonal antibody (A) and by
TPS-A (B).
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5.61 102 2.92 102 (SP) and 8.66 104 3.56 104
(non-SP) (n ¼ 4, mean S.E.) (Fig. 3B). Statistical analysis
showed that the ABCG2mRNA expression level in SP cells was
signiﬁcantly higher than in non-SP cells (P ¼ 0:029).
3.4. Distribution of ABCG2-expressing cells
Our immunoﬂuorescence data using BXP-21 monoclonal
antibody speciﬁc for human ABCG2 revealed that ABCG2 is
expressed in the limbal epithelial basal cells (Fig. 4A, B), but
not in corneal epithelial cells (Fig. 4C). Observed ABCG2
expression in basal cells is inconsistent and discontinuous in
the epithelium, and does not persist throughout the entire
limbus (Fig. 4A). Fig. 4B shows that positive staining cells are
present not only in the basal but also in the suprabasal cells.4. Discussion
Corneal epithelial stem cell deﬁciency caused by ocular
trauma or diseases causes corneal opaciﬁcation and visual loss.
Patients with corneal epithelial stem cell deﬁciency can be
treated with autologous or allogenic limbal transplantation
[24,25]. However, autologous limbal transplantation requires a
large limbal withdrawal from the patient’s eye, and allogenic
limbal transplantation has a signiﬁcant risk of rejection.
Moreover, shortage of donor tissues is a serious current
challenge. To avoid these problems, transplantations of culti-
vated corneal limbal epithelial cells have recently been reported
[26–31]. In such tissue engineering approaches, development of
new, eﬀective methods for rapid identiﬁcation and enrichmentof corneal epithelial stem cells would be a considerable ad-
vantage since long-term, functional recovery of corneal epi-
thelium is linked to graft constructs that retain viable stem cell
populations [26,28,32].
In this study, we examined whether human limbal epithe-
lium contains cells with SP phenotype, similar to stem cells in
other organs [6,10–16]. Hoechst 33342 dye exclusion assays
revealed that a number of SP cells are present in the limbal
epithelium but not in the corneal epithelium (Fig. 1). The mean
percentage of SP cells in limbal epithelial cells obtained from
six independent experiments was calculated to be 0.29% (data
not shown). This is a reasonable abundance value compared
with that previously reported in other organs [6,10–16].
Though verapamil is generally used to identify the SP pheno-
type in the Hoechst 33342 dye exclusion assay, it is insuﬃcient
in speciﬁcity to demonstrate the contribution of ABCG2 to the
SP phenotype of limbal epithelial cells. As ABCG2-speciﬁc
inhibitors, fumitremorgin C [33], 5D3 monoclonal antibody
Fig. 4. Expression patterns of the ABCG2 marker using immuno-
markers. Distribution of cells expressing ABCG2 protein was exam-
ined by immunoﬂuorescence staining using the BXP-21 monoclonal
antibody. (A) The basal layer of the limbal epithelium was inconsis-
tently and discontinuously stained with anti-ABCG2 antibody (green).
(B) A higher-magniﬁcation view of the limbal region showed that
positively stained cells are present not only in the basal but also in the
suprabasal cells. (C) ABCG2 was not expressed in the corneal epi-
thelium. Nuclei were labeled with propidium iodide (red). Scale bar:
100 lm (A), 50 lm (B, C).
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epithelial cells using 5D3 and TPS-A showed that both 5D3
and TPS-A eﬀectively inhibit Hoechst 33342 dye eﬄux from
these cells (Fig. 2A, B). These data strongly suggest a corre-
lation between SP phenotype and ABCG2 expression, but the
possibility of partial contribution of other transporters to SP
phenotype cannot be excluded. Real-time quantitative RT-
PCR analysis showed a strong correlation between ABCG2
expression and the SP phenotype. The ABCG2 mRNA ex-
pression indices in SP and non-SP cells varied considerably
between samples, but SP cells consistently expressed a signiﬁ-
cantly higher level of ABCG2 mRNA over non-SP cells
(Fig. 3B). The variation observed in these experiments may be
due to variable conditions of eye bank tissue samples aﬀected
by many uncontrolled factors including donor age, death-to-
preservation time and tissue storage time.
Immunoﬂuorescence work revealed that ABCG2 was in-
consistently expressed within the basal layer of the limbal
epithelium (Fig. 4A), but not in the corneal epithelium
(Fig. 4C). These observations also indicated that ABCG2 po-
sitive cells are present not only in the basal but also in the
suprabasal cells in some areas (Fig. 4B). This localizationpattern for ABCG2-positive cells coincides almost identically
with that for corneal epithelial stem cells demonstrated previ-
ously by several investigators [1,2,34–37]. These ﬁndings imply
that ABCG2 positive cells in the limbal epithelium are putative
corneal epithelial stem cells, consistent with the observation
that SP cells are present in the limbal epithelium but not in the
corneal epithelium (Fig. 1). Flow cytometry revealed that SP
cells are only 0.20% of total limbal epithelial cells (Fig. 1A),
but immunoﬂuorescence showed that many more cells express
ABCG2 (Fig. 4A, B). Because limbal epithelial basal cells have
a small cytoplasmic volume, it is not clear whether ABCG2
molecules localize in the plasma membrane or in the cytoplasm
(Fig. 4A, B). Since it has been reported that active ABCG2 is
expressed on the surface of SP cells, and cytoplasmic ABCG2
cannot eﬄux Hoechst 33342 dye outside these cells
[19,21,38,39], the smaller number of SP cells observed here can
be explained by possible cytoplasmic localization of ABCG2.
In addition, it is possible that our methods actually underes-
timate functional SP populations in limbal epithelial cells: cells
were collected from eye bank eyes with varying death-to-
preservation times and storage conditions, with the likelihood
that viability, including dye eﬄux capability, might be reduced.
One possible biological function of ABCG2 expressed in the
limbal epithelium is a protective function. Because Bcrp1/
ABCG2 is known to transport a variety of toxic lipophilic
compounds [40–42], ABCG2 may protect corneal epithelial
stem cells from cytotoxic agents. Recently, Jonker et al. [43]
found that Bcrp1/ABCG2-null mice become extremely sensi-
tive to the dietary chlorophyll-breakdown product, pheo-
phorbide a, resulting in severe, sometimes lethal, phototoxic
lesions on light-exposed skin. This ﬁnding suggests that
ABCG2 may protect corneal epithelial stem cells from solar
damage. This is also consistent with the assertion that corneal
epithelial stem cells are protected from solar damage by mel-
anin pigmentation of the limbus in non-Caucasian people [2].
Another possibility is that ABCG2 may regulate the develop-
ment of corneal epithelial stem cells by functioning as trans-
porters of small hydrophobic regulatory molecules involved in
proliferation, diﬀerentiation, or apoptotic pathways. However,
the function of ABCG2 expressed in limbal epithelial basal
cells remains a subject for further investigations.
In summary, our results suggest that the SP cell phenotype
and cellular surface expression of ABCG2 may characterize
putative corneal epithelial stem cells. Thus, ABCG2 may serve
as a useful cell surface marker in the enrichment of viable
corneal epithelial stem cells, and could be readily exploited for
new tissue engineering approaches that attempt to reconstruct
damaged ocular surfaces using cell transplantation methods.
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